10x Genomics Inc. trailing returns
How 10x Genomics Inc. (TXG) has performed over the last day, week, month and year, over 5 years, and since inception, through October 16, 2026 — price return and dividends side by side, with the worst drop inside each window.
Trailing returns by period#
To 2026-10-16. Price return + dividends = total return. Per year (CAGR) for windows of a year or more, with the cumulative total return beneath. Worst drop: the deepest fall in the price from a high inside the window, and when it bottomed.
| Period | Price | DivsDividends | Total | Worst drop |
|---|---|---|---|---|
| 1 day | -3.5% | +0.0% | -3.5% | — |
| 5 days | -13.4% | +0.0% | -13.4% | -13.4%Oct 16 |
| 1 month | -3.9% | +0.0% | -3.9% | -28.5%Oct 16 |
| YTD | +328.3% | +0.0% | +328.3% | -28.5%Oct 16 |
| 1 year | +464.3% | +0.0% | +464.3% | -28.5%Oct 2026 |
| 5 years | -14.4% | +0.0% | -14.4%-54.1% | -96.1%Apr 2025 |
| Since inception (2019) | +4.0% | +0.0% | +4.0%+32.4% | -96.5%Apr 2025 |
Growth of TXG#
Actual level with dividends reinvested (solid); dashed lines are each window's constant-rate path from start to today.
- 5 years-14.4%/year · -54.1%
Methodology#
Trailing returns measure from the closest close about N years before the latest close (2026-10-16). Cumulative return is the total change over the window; annualized return is the compound annual growth rate (CAGR), shown for windows of a year or more. Price return is the change in TXG's closing price; total return reinvests dividends (from its split- and dividend-adjusted closes); the dividends column is the difference between the two. The worst drop is the largest fall in the closing price from a high to a later low inside the window, the way a drawdown is usually quoted. See the year-by-year returns for the calendar breakdown. Past performance does not predict future returns; not investment advice.
FAQ#
- What is 10x Genomics Inc.'s return since inception?
- Since 2019, 10x Genomics Inc. (TXG) has compounded at about +4.0% a year — +32.4% in total.